NCT02754219View on ClinicalTrials.gov

Pharmacokinetics and Safety of Evogliptin in Subjects With Hepatic Dysfunction

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 22, 2016

Primary Completion Date

January 19, 2018

Study Completion Date

January 19, 2018

Conditions
Liver Dysfunction
Interventions
DRUG

Evogliptin

DPP4-inhibitor, Evogliptin

Trial Locations (1)

Unknown

Severance Hospital Clinical Trial Center, Seoul

All Listed Sponsors
lead

Dong-A ST Co., Ltd.

INDUSTRY

NCT02754219 - Pharmacokinetics and Safety of Evogliptin in Subjects With Hepatic Dysfunction | Biotech Hunter | Biotech Hunter